Happify Health launched Kopa, a platform targeted towards people with chronic conditions. The first component of this new platform is Kopa for Psoriasis, a...
Janssen Pharmaceutical’s TREMFYA® One-Press, a single-dose, patient-controlled injector for adults with moderate-to-severe plaque psoriasis received FDA approval. TREMFYA is the first FDA-approved medication of...
Boston-based LEO Science & Tech Hub, an R&D innovation unit of Leo Pharma that explore cutting-edge science and technology opportunities with relevance for dermatology,...